Dr. Matthew Lee Rohlfing, MD

Dr. Rohlfing practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Rohlfing's NPI, 1063874238, was assigned on March 25, 2016. Dr. Rohlfing graduated from Wake Forest University School of Medicine in 2016. Dr. Rohlfing holds Missouri license 2022024221.

Dr. Rohlfing's primary practice is Washington University School of Medicine, at 4921 Parkview Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 996-3845.

Dr. Rohlfing's primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Rohlfing is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Rohlfing to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rohlfing practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rohlfing's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Rohlfing is licensed in Missouri.

CMS data shows 4,676 Medicare services from Dr. Rohlfing across 13 procedure codes in 2024, for 337 Medicare patients. Medicare paid $135,111 for them.

CMS counts 337 Medicare patients who saw Dr. Rohlfing in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rohlfing's median patient age at 68, with 64% women.

In 2024, Dr. Rohlfing wrote 408 Medicare Part D claims for 114 patients. 99% of them were for generic drugs. CMS names the drug for 313 of them, across 7 drugs with 11 or more claims each, at $3,978 in total drug cost. In 2023, CMS named 152 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Rohlfing for performance year 2024, reported as part of a group. Dr. Rohlfing accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rohlfing as offering telehealth. CMS counts 17 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Rohlfing, more than 48% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Rohlfing, published from 2013 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Vocal Cords, Glottis and Laryngoscopy. Dr. Rohlfing has published most often in Laryngoscope. Dr. Rohlfing's most frequent co-authors are Jessica R. Levi, MD, Christopher D. Brook, MD and Alexander H. Gelbard, MD.

CMS Open Payments shows 5 general payments to Dr. Rohlfing from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Steris Corporation paid the most, $61.

Dr. Rohlfing graduated from Wake Forest University School of Medicine in 2016.